Komori
Heiwa Real Estate (8803) · RiskRestated

Risks of Large-Scale Share Purchases That Could Impair Corporate Value and the Common Interests of Shareholders

First written in FY2017-Q1. 16 of 17 entries say "Restated". Latest entry: FY2024-Q2.

17entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2024-Q22016: 220162017: 320172018: 320182019: 220192020: 120202021: 020212022: 320222023: 32023
Same theme, other companies
Large-Scale Share Purchases and Acquisition Proposals that May Damage Enterprise ValueA theme 119 companies write about · 120 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 3 of 26 companies on the "Worse" side.

86 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 119 companies compared. The sentences above are computed from all 119.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    It is stated that there have been no new developments or material changes in the risk that large-scale purchases could impair corporate value and the common interests of shareholders.
  2. FY2024-Q1RestatedAnnual report

    「No new business or other risks arose during the first quarter of the current consolidated cumulative period. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    It is stated that there have been no new developments or material changes in the risk that large-scale purchases could impair corporate value and the common interests of shareholders.
  3. FY2023-Q3RestatedAnnual report

    「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    It is stated that there have been no new developments or material changes in the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders.
  4. FY2023-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    It is stated that there have been no new developments or material changes in the risk that large-scale purchases could impair corporate value and the common interests of shareholders.
  5. FY2023-Q1RestatedAnnual report

    「No new business or other risks arose during the first quarter of the current consolidated cumulative period. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    It is stated that there have been no new developments or material changes in the risk that large-scale purchases could impair corporate value and the common interests of shareholders.
  6. FY2022-Q3RestatedAnnual report

    「Some large-scale purchases and similar transactions may impair the corporate value we have continued to enhance and the common interests of our shareholders.」

    The recognition of the possibility that large-scale purchases could impair corporate value and the common interests of shareholders has been reaffirmed. It is stated, in conclusion, that there are no new risks or material changes.
  7. FY2021-Q2RestatedAnnual report

    「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    It is stated that there have been no material changes in the risk that large-scale purchases could impair corporate value and the common interests of shareholders.
  8. FY2020-Q1RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reaffirmed.
  9. FY2019-Q3RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reaffirmed.
  10. FY2019-Q2RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reaffirmed.
  11. FY2019-Q1RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reaffirmed.
  12. FY2018-Q3RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reiterated.
  13. FY2018-Q2RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reiterated.
  14. FY2018-Q1RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reiterated.
  15. FY2017RestatedAnnual report

    「Some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the possibility that large-scale purchases could impair corporate value and the common interests of shareholders has been reiterated.
  16. FY2017-Q2RestatedAnnual report

    「However, some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The recognition of the risk associated with large-scale purchases that could impair corporate value and the common interests of shareholders has been reiterated.
  17. FY2017-Q1First statedAnnual report

    「Some large-scale purchases of shares may impair the corporate value of the target company and, consequently, the common interests of its shareholders, effectively compel the target company’s shareholders to sell their shares, or fail to provide the target company’s Board of Directors or shareholders with sufficient time or information to consider the details of the purchase or for the Board of Directors to propose an alternative. Such purchases may therefore impair the corporate value of the target company and the common interests of its shareholders.」

    The risks described include large-scale purchases that could impair corporate value and the common interests of shareholders, coercion to sell, and insufficient time or information for consideration.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Heiwa Real Estate's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.